Evidence map›Paper›PMID 29563155›Full record

ArticleThe Journal of biological chemistry2018

Sorting nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2.

Zhe Yang, Jordan Follett, Markus C Kerr, Thomas Clairfeuille, Mintu Chandra, Brett M Collins, Rohan D Teasdale

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Autophagy in Inflammatory Response against SARS-CoV-2.International journal of molecular sciences · 2023
    Review
  10. Receptor Recycling by Retromer.Molecular and cellular biology · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Review
  16. Review
  17. Retromer dysfunction at the nexus of tauopathies.Cell death and differentiation · 2021
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhe YangFrom the School of Biomedical Sciences, Faculty of Medicine, and.
Jordan FollettInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
Markus C KerrInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
Thomas ClairfeuilleInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
Mintu ChandraInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
Brett M CollinsInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia.
Rohan D TeasdaleFrom the School of Biomedical Sciences, Faculty of Medicine, and R.Teasdale@uq.edu.au.
University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alanine-, serine-, cysteine-preferring transporter 2 (ASCT2, SLC1A5) is responsible for the uptake of glutamine into cells, a major source of cellular energy and a key regulator of mammalian target of rapamycin (mTOR) activation. Furthermore, ASCT2 expression has been reported in several human cancers, making it a potential target for both diagnostic and therapeutic purposes. Here we identify ASCT2 as a membrane-trafficked cargo molecule, sorted through a direct interaction with the PDZ domain of sorting nexin 27 (SNX27). Using both membrane fractionation and subcellular localization approaches, we demonstrate that the majority of ASCT2 resides at the plasma membrane. This is significantly reduced within CrispR-mediated SNX27 knockout (KO) cell lines, as it is missorted into the lysosomal degradation pathway. The reduction of ASCT2 levels in SNX27 KO cells leads to decreased glutamine uptake, which, in turn, inhibits cellular proliferation. SNX27 KO cells also present impaired activation of the mTOR complex 1 (mTORC1) pathway and enhanced autophagy. Taken together, our data reveal a role for SNX27 in glutamine uptake and amino acid-stimulated mTORC1 activation via modulation of ASCT2 intracellular trafficking.

Indexed as

Amino Acid Transport System ASCAutophagyCell CycleCell ProliferationClustered Regularly Interspaced Short Palindromic RepeatsGene Knockdown TechniquesGlutamineHeLa CellsHumansLysosomesMechanistic Target of Rapamycin Complex 1Minor Histocompatibility AntigensPDZ DomainsProtein TransportSignal TransductionSorting NexinsAmino Acid Transport System ASCGlutamineMechanistic Target of Rapamycin Complex 1Minor Histocompatibility AntigensSLC1A5 protein, humanSNX27 protein, humanSorting Nexinsautophagycell cycleglutaminelysosomemammalian target of rapamycin (mTOR)plasma membranesorting nexin (SNX)

Identifiers

PMID29563155
PMCPMC5936802
OpenAlexW2792754202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.